Overview

Hu Yamei (Chinese: 胡亚美; born 27 April 1923, died 3 October 2019) was a prominent Chinese physician and medical researcher who specialized in pediatric hematology and oncology. She served for many years as the president of Beijing Children’s Hospital and was nationally recognized for advances in the diagnosis and treatment of childhood leukemia.

Name and background

The subject’s personal name appears in Chinese naming convention as a two-character given name; this is a Chinese name and the family name is Hu. Her medical career unfolded primarily in Beijing, where she combined clinical work, hospital leadership and research.

Career and research

Hu rose through clinical ranks to lead one of China’s foremost pediatric hospitals. Her investigations focused on childhood blood disorders, especially leukemia, at a time when survival rates were improving worldwide due to better chemotherapy protocols, supportive care and infection control. She is credited with treating and helping to cure more than 700 children with leukemia, reflecting both individual clinical success and wider improvements in pediatric oncology in China.

Institutional roles and initiatives

In addition to heading Beijing Children’s Hospital, Hu co-founded the Beijing Hu Yamei Children’s Medical Research Institute (commonly abbreviated BHI). Under her leadership the institute promoted clinical research, training for pediatric specialists, and protocols that were disseminated to hospitals across the country. Her appointment as an academician of the Chinese Academy of Engineering in 1994 acknowledged her combined contributions to medicine and medical science administration.

Contributions and importance

  • Clinical impact: direct treatment of hundreds of children with leukemia and mentorship of pediatric clinicians.
  • Research and education: fostering clinical studies and specialist training within pediatric hematology/oncology.
  • Leadership: guiding one of China’s leading pediatric hospitals and founding a research institute to sustain progress.

Legacy

Hu Yamei’s career spanned decades of change in Chinese medicine. As a hospital leader, researcher and educator she played a notable role in improving outcomes for children with serious blood disorders. Her death on 3 October 2019 was reported by medical circles and institutions in Beijing, and her professional life continues to be cited in discussions of the development of pediatric oncology in modern China.